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bial, antiviral, anticancer, anti-inﬂammatory, analgesic, etc. The substituted benzimidazoles are sum-
marized in this review to know about the chemistry as well as pharmacological activities.
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Imidazole is the accepted name for the parent compound in the
series, the numbering of which follows the accepted pattern for
heterocyclic compound. Imidazole or iminazoline is an azapyr-
role, the nitrogen atom is separated by one carbon atom. This
compound was earlier also called as glyoxalin as it was ﬁrst
prepared in 1958 from glyoxal and ammonia.
S158 Salahuddin et al.The benzo derivative of imidazole is referred to as benz-
imidazole (Bansal, 2002). Although benzimidazole is the com-
monest name of the parent compound of the series, other
names such as benzimidazole and 1,3-benzodiazole (1) are of-
ten used.
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Mono acyl derivative of o-phenylenediamine is readily con-verted into the corresponding benzimidazole by the action of
heat alone. These conversions are generally carried out at a
temperature somewhat above the melting point of the starting
compounds. This is a convenient method for preparing benz-
imidazoles when monoacyl derivatives are easily obtainable.
The procedure may be improved by heating the monoacyl
derivative of diamine in an atmosphere of nitrogen to prevent
oxidation (Kelly, 1945).The diacyl derivatives of o-phenylen-
ediamines are also converted into benzimidazoles but higher
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HBenzimidazole is also synthesized from o-phenylenediamine
and mono or di-basic acid. In this method, the diamine is sim-
ply heated with excess acid (Fischer, 1905).This procedure has
been recommended as a means of identifying fatty acid a-hy-
droxy acid as well as phenylacetic acid and diphenylacetic acid
are converted into the corresponding benzimidazoles when
heated with o-phenylenediamine.
Phillips modiﬁcation of the above procedure consists in
reﬂuxing with the (Philips, 1928) o-phenylenediamine andmono basic acid in 4 N hydrochloric acid. The benzimidazole
is then precipitated by neutralizing the solution with ammo-
nium hydroxide. Benzoic acid gives only traces of 2-phenyl-
benzimidazole. Apparently this method is not applicable to
the aromatic monobasic acid.
Benzimidazole derivative are associated with various types
of pharmacokinetic and pharmacodynamic properties. Benz-
imidazole nucleus is one of the bioactive heterocyclic com-
pounds that exhibit a range of biological activities.
Speciﬁcally, this nucleus is a constituent of vitamin B12 (O’Neil
et al., 2001).The pharmacological activities of the benzimid-
azole containing moiety have been well documented (Amari
et al., 2002). Albendazole, Mebendazole and Thiabendazole
are widely used as anthelmintic drugs (Kohler, 2001).
Literature survey reveals that the various derivatives of
benzimidazole have been synthesized for their pharmacological
activities. Some of the already synthesized compounds from
the above mentioned ﬁeld have found very strong application
in medicine praxis (Mavrova et al., 2006). The activity against
bacteria, fungi and helminthes resulted their mode of
action, which resulted in the blockage of microtubule in
various nematode, trematode and cystode. (Campbell and
Denham, 1983).2. Antimicrobial
The two series of benzimidazole derivatives were synthesized,
the ﬁrst one was based on 2-thioalkyland thioaryl substi-
tuted benzimidazole (6), the second one was based on 5,6-
dinitrobenzimidazole (7) and the antibacterial activity of
the compound against nosocomial strains of Stenotropho-
monas malthophilia was examined (Kazimierczuk et al.,
2002).
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ated for their antibacterial activity against Bacillus subtilis,
Escherichia coli, Candida albicans, Aspergillus niger and Asper-
gillus ﬂavus. The tested compounds are more effective against
gram positive bacteria. The strong lipophilic character of mol-
ecule plays an essential role in producing antimicrobial effects
(Ansari and Lal, 2009a,b).N
N
CH
(8)
R= C6H5, 4-BrC6H5, 2-ClC6H4, 4-C6H4, 2-OCH3Some derivatives of benzimidazole were synthesized by
nucleophilic substitution of substituted benzimidazole 2-
substituted-1-[{(5-substituted-alkyl/aryl)-1,3,4-oxadziazolyl-2-
yl}] (9) and were evaluated for antimicrobial activities toward
Gram +ve and Gram –ve bacteria. Some of the synthesized
compounds showed moderate activity against tested fungi
(Ansari and Lal, 2009a,b).3
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R= H or CH3
R1= CH3, C2H5, CH2Cl, C6H5, 2-ClC6H4, 4-ClC6H4, 2-OHC6H4, 4-OHC6H4, 2-OCH3C6H4, 4-
OCH3C6H4 
N
N
H
SR
(10) 
R= 2,4-DNP, 2,6-DNP, 2,4,6-TNP, 2-chloro 4,6-DNP, 2-methyl- 4,6-DNP, 2-chloro-4-
bromo-3,5-DNP(DNP= dinitrophenyl, TNP= trinitrophenyl) 
S160 Salahuddin et al.Gupta and Rani (1977) synthesized 2-thiohalogenonitro-
phenyl benzimidazole by the condensation of halogenonitro-
benzenes and sodium salt of 2-mercaptobenzimidazole (10)
and tested for their antifungal activity againstHelmithosporium
sativum, A. niger and Fusarium oxysporum by spore germina-
tion method. The percentage inhibition of the spores at
10 ppm has been recorded.
Ghoneim et al. (1998) synthesized 2-[(4-aminophenyl)sul-
phonyl] derivative (11) of benzimidazole and tested the antimi-
crobial activity of compounds against E. coli using agar
diffusion method.
N
N
H
S
O
O R
(11) 
R= 4-NH2 and 2,4-diNH2
All 4-amino and 2,4-diaminophenylsulphonyl derivatives
showed antimicrobial activity.
Various benzimidazoles (12) were prepared and evaluated
by Mane et al. against Alternariabrassicicola, Fusarium, Staph-
ylococcus (Gram+ve) andE. coli (Gram –ve) using ﬁlter paper
disc method at 500 ppm concentration using 5 mm size ﬁlter
paper. It was found that the compound having NO2 and
chloro substituent showed good activity against fungi as well
as bacteria (Mane et al., 1995).H2C COR2
COR1
R
H3C
COR1H3C
(12) 
R= H, CH3, C2H5, C6H5
R1= CH3, OCH3, OC2H5
R2= H, 4-CH3, 4-OCH3, 3-Cl, 3-NO2, 4-NO2, 4’-OH
A series of fused and spiropyrazolones (13), isoxazolines
(14), pyrimidines (15), b-lactam (16) and thiazolidinones (17)
incorporating 2-cyanomethyl benzimidazole were synthesized
by Khalafallh et al. (1995).
The synthesized compounds have been tested against some
bacterial and fungal strains using the ﬁlter paper disc method
and 3-cyano-2,3dihydropyrolo[1,2-a]benzimidazole-1(H)-one
is more potent against bacteria and fungi than pyrazolines
and pyrimidines.
Kumar et al. (2006) synthesized some novel 2-(6-ﬂurochro-
man-2-yl)-1-alkyl/acy/aroyl-1-H-benzimidazoles (18) with dif-
ferent types of electrophiles. Some of the compounds show
NN
NN
CN
O
C H3
X
N
N
CN
NH
N
S
X
(13, 14)      (15) 
X= H, P-NO2, P-(NCH3)2 
N
N
CN
O
Cl
O
R
N
N
CN
N
S
O
R
(16)       (17) 
R= OH, 4-N-(CH3)2, 2-OH, 4-benzosubstituted, 5,6- benzosubstituted 
N
N
O F
R
(18) 
R= CH3, C2H5, -CO-Phenyl, -So2-phenyl, Benzyl, p-fluorophenyl 
N
N
H
N
O
NR
N
N
H
N
O
N
NH2
(19)       (20) 
N
N
H
N
O
NRO2SHN
N
N
H
N
O
NRCONH
(21)       (22) 
R= aryl 
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S162 Salahuddin et al.good antibacterial activity against Salmonella typhimurium and
poor activity against Staphylococcus aureus.
Kaghtara et al. (1999) reported when 2-(benzimidazol-2-yl)
benzoyl hydrazide condensed with any aromatic acid and
POCl3 gives 2-aryl-5-[(2
0-benzimidazol-200-yl)phenyl]-1,3,4-
oxadiazoles (19). The acid hydrazide on cyclization with CNBr
yields 2-amino-5-[20-(benzimidazol-200-yl-phenyl)-1,3,4-oxadi-
azole (20) which on reaction with any sulphonyl chloride and
substituted benzoyl chloride gives the corresponding sulphona-
mides (21) and amides (22) respectively. All the synthesized
products have been evaluated in vitro for their antimicrobial
activity against several microbes.
Bishnoi et al. (2002) reported various 10-(a-p-benzimidazol-
yl-aminobenzyl)phenothiazines (23). All the compounds were
evaluated for their antifungal activity against Fusarium solani.
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R= H, CH3 A new series of 2-substituted-1-[(5-substituted-phenyl-1,3,4-
oxadiazole-2-yl)methyl-1H-benzimidazole (24) have been syn-
thesized. The newly synthesized compounds were evaluated
for their antibacterial activity (MIC in lg/mL) by the serial
dilution method in vitro against Gram positive bacteria namely
E. coli, S. aureus and Gram negative bacteria namely Pseudo-
monas aeruginosa (Gowda et al., 2010).
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R1= Propyl, Benzyl R2= H, Cl, Br, Me, OMe,
The 1H-benzimidazole-2-yl thioacetylpiperazine derivatives
(25, 26, 27) were synthesized and evaluated for their in vitro
activity against T. spiralis as well as their in vivo antinematode
activity against S. obvelata (Mavrova et al., 2006). The in vitro
activity showed that most of the tested compounds exhibit
higher activity than albendazole against T. spiralis and compa-
rable to that of ivermectin. Some of the compounds demon-
strated 96.0%, 98.2% and 100% activities at a dose of
200 lg/mL after 48 h. Some of the compounds were found
most active with 76%, 73% and 77% against S. obvelata.N
N
H
S
N
N
O
R
R1
 (26) 
R= H, CH3, NO2, Cl R1= CH3, Cl 
S N
H
N CH3
NN
N
N
N
CH3
R
SR'
(28) 
R=  CH3, C2H5, CH(CH3)C2H5, (CH2)3CH3, CH2Ph, CH2COOC2H5,  CH(CH3
N
N
CH3
CH2CH2
O
N N
SH
N
N
CH3
CH2CH2
N
O
N
S
CH2-N(C2H5)2
(29)       (30) 
N
N
CH3
CH2CH2
N
N N
SH
NH2
N
N
CH3
CH2CH2CONHN=CH
(31)   (32) 
O
C H3
CH3
C H3
O H
O
NN
NHR
(33) 
R= Aryl 
Benzimidazoles: A biologically active compounds S163A series of 1-[(4-(40-substituted)phenyl-3-alkyl/aralkyl-thio-
4H-1,2,4-triazoles (28) have been prepared and screened for
their antimicrobial activity against pathogenic organisms S.
citrus, B. subtilis and E. coli and antifungal against A. fumiga-
tus, C. albicans and F. heterosporum by single disc method at
different concentration method (50 and 100 lg/mL) using
ampicillin and miconazole as standard drugs for antibacterial
and antifungal activities respectively (Shetgiri and Kokitkar
2001)
5-[2-(2-Methylbenzimidazol-1-yl)ethyl][1,3,4]oxadiazole-
2(3H)-thione (29), 5-[2-methylbenzimidazol-1-yl)ethyl]-3-dieth-
ylaminoethyl (30), 5-[2-(2-methylbenzimidazol-1-yl)ethyl]-4-
amino[1,2,4]triazole-3-thiol (31), 3-(2-methylbenzimidazol-1-
yl)propionic acid hydrazide Schiff’s base (32) have been synthe-
sized and were tested for their antimicrobial activity against
Gram +ve bacteria (Bacillus cereus), and Gram –ve bacteria
(E. coli) (AfafH El-masry et al., 2000).
2-Arylamino-5-(p-nitrosothymoxymethyl)-1,3,4-oxadiaz-
oles (33) were prepared along with their derivatives by chemo-
selective heterocyclization with NaOH/I2 of thiosemicarbazide.
The compounds were screened for their antimicrobial activity
against Gram +ve bacteria S. citrus and B. mega and against
Gram –ve bacteria E. coli and S. typhosa and for antifungalactivity againstA. niger by the cup plate method at a concentra-
tion of 50 lg/mL using DMF as a solvent. The activity was
compared with the known standard drug viz. ampicillin, chlor-
amphenicol, norﬂoxacin and griseofulvin at same concentra-
tion (Vashi et al., 1996).The efﬁcient and rapid synthesis of novel azetidin-2-ones
(34) has been established. Thus, both microwave and conven-
tional condensation of 2-{(1H-benzimidazol)-ylthio}-N0-2-
(substituted phenyl) hydrazide with chloroacetylchloride were
NN
H
S
NH N
O O
Cl
R
(34) 
R= 4-NO2, 3,4,5-(OCH3)3, 3-OH,4-OH, 5-OH, 2-OCH3, 4-OCH3, 2-Cl, 3-Cl, 4-Cl
S164 Salahuddin et al.carried out in DMF-benzene solvent in the presence of Et3N
catalyst. The resulting compounds have been evaluated for
their antibacterial activity against B. subtilis, S. aureus and
E. coli.3. Antiviral
Some 7-(arylamidoalkyl)-3,4-diphenyl-isoquinolinyl-[1,5-c]-
benzimidazoles (35) have been synthesized and were evaluated
for their in vivo against inﬂuenza virus (IV) by inoculating it in
10 day old embryonated hen’s egg at the concentration of
0.5 mg per embryo in allantoic cavity. After 48 h it was found
that the isoquinonyl benzimidazole derivative with nicotinam-
ido group showed the maximum activity (Pandey and Shukla
1999).
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(35) 
R= H, R’= SalicylamidoN
H
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CHSCNHR'
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S
 (36)                                            
N
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S
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(38)                                             Various benzimidazol-2-ylalkyl N-aryldithiocarbamates
(36), 2-arlimino-4-methyl/H-2H, 4H[1,3,4]dithiazino[4,5-a]
benzimidazole (37), 1-aryl-4-methyl/H-1, 2-dihydro-4H-[1,3,4]
thiadiazino[4,5-a]benzimidazole-2-thiones (38) 1-aryl-4-methyl
/H-1, 2-dihydro-4H-[1,3,4]thiadiazino[4,5-a]benzimidazole-2-
ones (39) were synthesized and tested for their antiviral activity
(Yadav and Pal, 1996).
A set of 2-substituted-5-amidino-benzimidazole (40) deriva-
tives bearing amidino substistuent at C-5 of benzimidazole ring
were synthesized by introducing various heterocyclic nuclei at
C-2 and were evaluated for their antiviral activity towards c
oxsackie viruses and echo viruses. The most selective activity to-
wards coxsackie viruses and echo viruses was observed with the
compound having pyridine ring at C-2 (Kristina et al., 2007).
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R1=  Heterocyclic substituent 
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thiazines (41) have been synthesized and their antiviral activity
was performed against JEV and HSV-1 (Bishnoi et al., 2002).
S
N
CH
NH
N
N
H
R
(41) 
R= Substituted phenyl 4. Anticancer
A novel series of benzimidazole substituted Schiff bases (42)
were synthesized by the reaction of aromatic aldehydes with
corresponding 2-aminobenzimidazoles. The synthesized Schiff
bases were tested on their antiproliferative activity in vitro
and exerted non-speciﬁc antiproliferative activity on the tested
cell lines at the highest tested concentration (Hranjec et al.,
2011).
Benzimidazole-4,7-diones substituted at position-2 were
synthesized via a microwave-assisted reaction using 2-chloro-
methyl-1,5,6-trimethyl-1H-benzimidazole-4,7-dione. Their antiN
N
H
R
(42)
R=H, Ar= N
R=H, Ar= N
C H3
R= CN, A
R=CH3, A
R=NO2, A
O
S
R= CN, A
R=CH3, A
R=NO2, A
R= H, Ar=
R= CN, Ar=
R= CH3, Ar= 
R= CN, Ar=
R= CH3, Ar=
R= NO2, Ar=cancer activity has been evaluated on colon, breast and lung
cancer cell lines. Among this 2,20-bis(chloromethyl)-1,10-di-
methyl-5,50-bi(1H-benzimidazole)-4,40,7,70-tetraone (43) was
shown to possess excellent cytotoxicity comparable to that of
mitomycin C (Gellis et al., 2008).
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N N
N
Cl
Cl
CH3
O
O
O
OC H3
(43) 
Various heterocyclic benzimidazole derivatives (44–47)
have been synthesized by the condensation of succinic acid,
homophthalic acid and 2,3-pyrazinedicarboxlic acid with vari-
ous substituted diamines under microwave irradiation. All
these compounds evaluated for anticancer activity at 50 mg/
kg po exhibit good anticancer activity against ovary (IGR-
OV-1), breast (MCF-7) and CNS (SF-295) human cancer cell
lines (Sondhi et al., 2010).
Some 1-methylene-2,3-diaryl-1,2-dihydropyrazino[1,2-
a]benzimidazoles (48) and some 1-(2-arylvinyl)-3-arylpyrazi-
no[1,2-a]benzimidazole derivatives (49) have been synthesized
and their anticancer activity was reported. It can be seen thatAr 
r=
r=
r=
N
CH3
CH3
r=
r=
r=
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CH3 N
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(46)                                                                  (47)
S166 Salahuddin et al.for all the compounds, log10GI50 values are smaller than –4.
Melphalan cis-diaminodichloroplatinum, one of the chemo-
therapeutic agents, was used as standard compound (Demira-
yak et al., 2002).N
N N
R1
Ar 
(48) (49)
R1= H,  CH3,  OCH3, Cl, R2= H, CH3, OCH3, Cl, NO2
Cl
Cl
Ar = 
,
Cl
,
O S
,
N
N N
CH2
R2
R1The synthesis of some series of benzimidazole like: 2-
[(4-oxothiazolidin-2-ylidene)-methyl (50) and (4-amino-2-
thioxothiazol-5-yl) benzimidazoles (51), 2-[(4-ﬂuorobenzylid-
ene (52) and cycloalkylidene)-cyanomethyl] benzimidazoles
was carried out (53). All the synthesized compound were eval-
uated against three cell lines representing three common forms
of human cancer i.e. human hepatocellular carcinoma cell line
(HEPG2), human breast adenocarcinoma cell line (MCF7)
and colon carcinoma cell line (HCT 116) (Refaat, 2010).Shaharyar et al. (2010) synthesized 2-{5-[(substi-
tuted)phenyl]-4,5-dihydro-1H-3-pyrazolyl}-1H-benzoimidaz-
ole (54) and 2-{5-[(substituted)phenyl]-1-phenyl-4,5-dihydro-
1H-3-pyrazolyl}-1H-benzimidazole (55) and screened at theNational Cancer Institute (NCI), USA for anticancer activity
at a single high dose (10 lM) in full NCI 60 cell panel. Among
the selected compounds, 2-[5-(3,4-dimethoxyphenyl)-1-phenyl-
4,5-dihydro-1H-3-pyrazolyl]-1H-benzimidazole was found to
be the most active candidate of the series and selected for fur-
ther evaluation at ﬁve dose level screening.
A novel series of trisubstituted benzimidazole and its
precursors were synthesized. The title compounds were evalu-
ated for inhibition against MDA-MB-231 breast cancer cell
NN
H
S
NH
O
OH
O
N
N
H
NR
S
O
OH C H3
S
(50)     (51) R=C6H5, CH2C6H5
N
N
H
R
CN
F N
N
H
R
CN
(CH2)n
(52) R= Cl, COOH          (53) R= Cl, COOH  n= 1 and 2
N
N
H
N NH
R
N
N
H
N N
R
(54)      (55)
R= Phenyl, 4-Methoxyphenyl; 4-Chlorophenyl; 4-Bromophenyl; 4-Fluorophenyl; 3,4- 
Dimethoxy phenyl; 2,6-Dichloro phenyl 
Benzimidazoles: A biologically active compounds S167proliferation. The results revealed that the compound N-(4-cy-
ano-3-(triﬂuoromethyl) phenyl)-4-ﬂuoro-3-nitrobenzamide
(56) was the potent inhibitor (Thimmegowda et al., 2008).
N
N
NH
O Cl
Cl
CF3
NC
F
(56) 5. Antiprotozoal
Some thieno[2,3-d]pyrimidin-4(3H)-ones containing ben-
zimidazol-2-yl-thioethyl- and benzimidazol-2-yl-methanethio-ethyl moiety in the second position of the pyrimidine ring
were synthesized in order to determine their antitrichinellosis
and antiprotozoal effects. The benzimidazole derivatives of thi-
eno[2,3-d]pyrimidin-4-(3H)-ones (57) exhibited higher activity
against Trichinella spiralis in vitro in comparison to albenda-
zole. The most active compound, 2-[2-(5-nitro-1H-ben-
zimidazol-1-yl)ethyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]
pyrimidin-4(3H)-one (58) revealed 95% activity at a dosage of
5 mg/kg. The compound 2-{2-[(5(6)-nitro-1H-benzimidazol-2-
yl)thio]ethyl}-5,6,7,8-tetrahydro[1]-benzothieno[2,3-d]pyrim-
idin-4(3H)-one exhibited 90% efﬁcacy (Mavrova et al., 2010).
Novel series of some hybrids from benzimidazole and pent-
amidine (59) were prepared and each compound was tested
in vitro against the protozoa Trichomonas vaginalis, Giardia
lamblia, Entamoeba histolytica, Leishmania mexicana, and
Plasmodium berghei. The tested compounds were compared
with pentamidine and metronidazole (Gomez et al., 2008).
Biphenyl benzimidazolesdiamidines (60) were synthesized
from their respective diamidoximes, through the bis-o-acet-
oxyamidoxime followed by hydrogenation. The target
compounds contain hydroxy and/or methoxy substituted
1,3-phenyl groups as the central space between the two ami-
dino bearing aryl groups. All the compounds have performed
NH
NS
N N
OH3CH2CH2CH2C
H3CH2CH2CH2C NH
NS
OH3CH2CH2CH2C
H3CH2CH2CH2C
S N
N
NO2
(57)       (58) 
N
NH
O O
NH
N
R2R2
R1 R1
O O
N H
NH2 NH2
NH
Pentamide
Hybridisation with benzimidazole
(59) 
R1= H, OCH3, CH3, CF3, NO2 R2= H, OCH3 
S168 Salahuddin et al.DNA binding studies [DTm values for poly(dA.dT)2] and
in vitro evaluation against Trypanosoma b. rhodesiense
(T.b.r.) and P. falciparum for the diamidino biphenyl benzim-
idazoles (Ismail et al., 2004).x
R4
R
R
A
(
X= N, CH  R1= H, OH  R2= H, 
A= p-(C=NH)NH2 Various chloro-, bromo and methyl-analogues of 1H-
benzimidazole (61–64), 1H-benzotriazole and their N-alkyl
derivatives (65–68) have been synthesized and evaluated
in vitro against the protozoa Acanthamoe bacastellanii. ItN
NH1
R2
3
A
60) 
OH, OMe R3= H, OMe R4= H, Me 
NN
H
CH3
CH3
CH 3
CH3
N
N
H
CH3
CH3
CH3
CH3
CH3
N
N
H
Cl
Cl
Cl
Cl
N
N
H
Br
Br
Br
Br
(61)   (62)       (63)      (64)    
N
N
N
H
H
Br
Br
H
N
N
N
H
H
Br
Br
Br
N
N
Cl
Cl
Cl
Cl R
N
N
Br
Br
Br
Br R
 (65)   (66)    (67)    (68) 
R= methyl, ethyl, propyl 
Benzimidazoles: A biologically active compounds S169was found that 5,6-dimethyl-1Hbenzotriazole (11) and 5,6-
dibromo-1H-benzotriazole (14) have higher efﬁcacy than
the antiprotozoal agent chlorohexidine (Kopanska et al.,
2004).
Padilla et al. (2009) reported the synthesis and antiproto-
zoal activity in vitro of 1-methylbenzimidazolederivatives (69)
substituted with chlorine atoms at the benzenoid ring and ami-
nocarbonyl, N-methylaminocarbonyl, N,N-dimethylamino-
carbonyl,ethoxycarbonyl, 1-hydroxyethyl and acetyl at
position-2. Some of the compounds are more active than met-
ronidazole, the drug of choice against Giardia intestinalis and
most of them against T. vaginalis. The most active group of
compounds for both parasites in this series is substituted with
2-ethoxycarbonyl.
The derivatives of 2-(tri-ﬂuoromethyl)benzimidazole (70)N
N
R1
R2
CH3
R3
(69) 
R1= R2= H, Cl 
R3= CONH2, CONHCH3, CON(CH3)2, CO2CH2CH3, CH(OH)CH3, COCH3 substituted at the 1-, 5-, and 6-positions have been synthesized
and tested in vitro against the protozoa G. lamblia, E. histoly-
tica, and the helminth T. spiralis. The tested compounds are
more active as antiprotozoal agents than albendazole and met-
ronidazole. One compound (20) was as active as albendazoleagainst T. spiralis. These compounds were also tested for their
effect on tubulin polymerization and none inhibited tubulin
polymerization (Vazquez et al., 2001).
N
N
R1
R2
R3
CF3
(70) 
R1= R2= H, Cl  R3=CH3 Various 1-H-benzimidazoles (71) have been synthesized and
tested in vitro against the protozoa G. lamblia, E. histolytica
and the helminth T. spiralis. The compounds were also tested
for the inhibition of rat brain tubulin polymerization and com-
pared with standard drug. Most of the compounds tested were
NN
H
R1
R2
R3
(71) 
R1= R2= H, Cl  R3= H, CH3, NH2, NHCO2CH3, SH, SCH3 
N
N
CF3
R2
R1
5
6
(72) 
R1= 5(6)-H, 5(6)-Cl, 5(6)-F, 5(6)-CF3, 5(6)-CN, 5-CF3, 6-CF3 R2= H, CH3 
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albendazole. None of the compounds was as active as albenda-
zole against T. spiralis (Valdez et al., 2002).
2-(Triﬂuoromethyl)-1H-benzimidazole derivatives (72) with
various bioisosteric substitutents (-Cl, -F, -CF3, -CN) were
prepared and tested in vitro against G. intestinalis and T. vag-
inalis in comparison with albendazole and metronidazole.
Some analogues had IC50 values <1 lM against both species,
which make them more potent than either standard (Vazquez
et al., 2006).
Some thio-alkylated and thio-arylated derivatives of c-
substituted benzimidazole (73) have been synthesized and eval-
uated as antiprotozoal activity against nosocomial strains ofS.
malthophilia using metronidazole as standard. One of the
tested compounds, 4,6,-dichloro-2-(4-nitrobenzylthio)-benz-
imidazole showed the most distinct antiprotozoal activity (Ka-
zimierczuk et al., 2002).
N
N
HCl
Cl
S
NO2
(73) 6. Anti-inﬂammatory and analgesic activities
Some 2-substituted benzimidazoles (74, 75) have been synthe-
sized by the condensation of o-phenylenediamine with 2-cou-maranonyl acetic acid derivatives and indole 3-acid and
evaluated their anti-inﬂammatory and analgesic activities.
The compounds were found to have signiﬁcant anti-inﬂamma-
tory activity at 50 mg/kg dose (Khan and Nandan, 1997).
N
N
H
CH2R
(74)
R= indolyl, 3-skatolyl, 1-[2-(3-indolyl)-ethyl] 
N
N
H
O
O
R'
R"
(75) 
R’= R”= H         R’= R” = PhenylR’ = H, R” = CH3
A new synthesis and their anti-inﬂammatory activity of a
group of 1H-benzimidazole (76) were reported. The compounds
were assessed on rat adjuvant arthritis screen and indomethacin
as standard compound. The result gave 30% or greater reduc-
tion in non injected paw volume compared to control together
with the result for indomethacin (Evans et al., 1996).
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(76)
R= H, R’= 4-ClC6H5, R’’= OMe
R= H, R’= 4-ClC6H5, R’’= OH
 R= Me, R'= 4-ClC6H4 R''= -O-(CH2)2-N
R=Me, R’=  4-ClC6H5, R’’= -(OMe)Me N
N
H
R=
OH
HO OH
OH
OH
O H
O H
OH, ,
N
N
H
 N
O
(78) 
R=CH3, C6H5R1= H, OSome imino sugars of methylbenzimidazole (77) have been
prepared and anti-inﬂammatory activity of the compounds
was studied by employing the cotton pellet granuloma bioas-
say in rats using indomethacin as reference standard. The
granuloma% inhibition values were determined for each com-
pound (Taha, 2005).
1-[2,3-(2-Phenylbenzimidazole)]2-methyl/phenyl-4-(3,4-
disubstituted benzylidine)-5-oxoimidazoles (78) have been syn-
thesized by condensing 2-(2/3 aminophenyl)benzimidazoles
with appropriate 2-methyl/phenyl-4-(3,4-disubstituted) oxazo-
line-5-ones in dry pyridine and screened anti-inﬂammatory
activity against carrageenan induced oedema (Mohan et al.,
1984).
A series of novel 5-substituted-1-(phenylsulphonyl)-2-meth-
ylbenzimidazole derivatives (79) have been synthesized. Com-
pounds were evaluated for their anti-inﬂammatory and
analgesic activities as well as gastric ulcerogenic effects by car-
rageenan-induced rat paw edema and acetic acid-induced
writhing in mice using indomethacin as standard (Gaba et al.,
2010).CH2
N CH
R
OH
OH
OH
OH
OH
OH
O H
HO
OH
OH
OH
HO
OH
OH
,
,
(77)
C
N
R
R2
R1
CH3R2= H, OCH3 
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CH3
S O
O
NH
R
(79) 
R= o-NH2C6H4, p-NH2C6H4, p-NH2C7H6 7. Conclusion
The new classes of reviewed substituted benzimidazole have a
wide variety of biological activities. The 2-substituted-1-[{(5-
substituted-alkyl/aryl)-1,3,4-oxadziazolyl-2-yl}] 3-cyano-2,3di
hydropyrolo[1,2-a]benzimidazole-1(H)-one has good antibac-
terial and antifungal activities respectively. The signiﬁcant
antiviral and anticancer activities are shown by 7-(aryl-
amidoalkyl)-3,4-diphenyl-isoquinolinyl-[1,5-c]-benzimidazole
and benzimidazole substituted Schiff bases, but they are asso-
ciated with some drawbacks like side effect, toxicity. So for
minimizing these drawbacks there is a need to synthesize some
new chemical compounds with better results.References
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